PointState Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
PointState Capital's SYNH Position: Q1 2022 in Review
PointState Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 35,000 shares — an estimated $3.59M sold.
PointState Capital first reported a position in SYNH in Q4 2017 and held it in 2 quarters. The position peaked at $21M in Q4 2017. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.
- PointState Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- PointState Capital sold 35,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $3.59M.
- PointState Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 2 quarters.
- PointState Capital's Syneos Health, Inc. Class A Common Stock position peaked at $21M in Q4 2017.
- 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.
Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.